[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biomarkers Market Research Reports & Industry Analysis

Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.

Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.

The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.

Publications found: 57
Sort by:

Biomarkers: Market Research Report

US$ 4,800.00

... and Others (miRNA Analysis and Others). The total market is also analyzed by the following Application Areas: Biomarker Discovery, Clinical Drug Development, and ... , Inc., Rules-Based Medicine, Inc., and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary ...

August 2011 1305 pages

China Monoclonal Antibody Industry Report, 2010-2011

US$ 1,700.00

China has been engaging in the R&D of monoclonal antibody industry for a long time, but still lags far behind the European and American countries in terms of industrialization. In 2010, the market...

July 2011 64 pages

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)

US$ 3,795.00

... growth will be seen. Developments that are linked in the press to 'personalized medicine' are many, and can at times be confusing. But there ... (where there are products on the market) for personalized medicine technologies in the following categories: Cardiac Markers, immunoassays Cardiac Risk Markers ...

February 2011 430 pages

Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases

US$ 1,184.00

Product description The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis ...

December 2010 172 pages

Global Monoclonal Antibody Market Analysis

US$ 1,200.00

Single User PDF Format: US$ 1,200.00 Multi-User License: US$ 1,600.00 Hard Copy: US$ 1,300.00 CD-ROM: US$ 1,300.00 Considered as an indispensable tool in the clinical and biotechnology...

November 2010 80 pages

Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers

US$ 1,394.00

The report “Antibody Technology Companies 2010 – A systematic guide through the landscape of antibody technologies and their providers” provides a description and ... range of possibilities, the selection of the most robust and adequate technologies fitting fitting to the product target profile has become more ...

November 2010 283 pages

Antibody Pipeline Database: 1-Year Subscription

US$ 1,638.00

... numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. ...

November 2010

Filters

Search

Publishers

2
3
1
1
1
3
2
1
5
1
2
1
1
2
10
1
2
2
4
1
2
2
1
1
1
4

Regions

41
7
2
2
2
1
1
1

Price

Date

Pages

Offers

1
2